Loading…
Philip L Johnson is EVP & Chief Financial Officer at Jazz Pharmaceuticals. OQRO lists 3 transactions filed with the SEC under this name, the latest on Jul 3, 2026, each linked to the official Form 4.
EVP & Chief Financial Officer
Disclosures on record
3
Companies involved
1
Jazz PharmaceuticalsJAZZ
3 disclosures · Mar 2026 – Jul 2026
Jun 30, 20263,343disclosed Jul 3
DetailsOfficial recordMar 5, 20262,615disclosed Mar 10
DetailsOfficial record